Literature DB >> 1720152

Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction.

D D Richman1, J C Guatelli, J Grimes, A Tsiatis, T Gingeras.   

Abstract

A sensitive and specific polymerase chain reaction (PCR)-based assay was developed for four mutations in the reverse transcriptase gene of human immunodeficiency virus type 1 that have been associated with zidovudine resistance. These mutations were correlated in 366 specimens with zidovudine chemotherapy and resistance. Mutations at these four codons were detected only after zidovudine therapy. The usual sequence of appearance of mutations was codons 215, 70, 67, and 219, although individual variations occurred. The degree of resistance was proportional to the number of mutations present, although variable susceptibilities with identical patterns of mutations suggested the likelihood that additional mutations contribute to resistance. The existence of both phenotypic and genotypic mixtures was documented as was the occasional selection of subpopulations with passage of virus in vitro. The many complexities of zidovudine resistance render the assay of limited use for application to individual patients; however, it could prove useful for correlating disease or therapy with the emergence of resistance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720152     DOI: 10.1093/infdis/164.6.1075

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Authors:  D Persaud; T Pierson; C Ruff; D Finzi; K R Chadwick; J B Margolick; A Ruff; N Hutton; S Ray; R F Siliciano
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 2.  Antiretroviral therapy : optimal sequencing of therapy to avoid resistance.

Authors:  Jorge L Martinez-Cajas; Mark A Wainberg
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Use of tissue culture cell lines to evaluate HIV antiviral resistance.

Authors:  Halina Krowicka; James E Robinson; Rebecca Clark; Shannon Hager; Stephanie Broyles; Seth H Pincus
Journal:  AIDS Res Hum Retroviruses       Date:  2008-07       Impact factor: 2.205

4.  Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences.

Authors:  G J Moyle
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 5.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates.

Authors:  C A Boucher; R van Leeuwen; P Kellam; P Schipper; J Tijnagel; J M Lange; B A Larder
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

7.  Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

Authors:  L Duan; O Bagasra; M A Laughlin; J W Oakes; R J Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.

Authors:  D L Mayers; A J Japour; J M Arduino; S M Hammer; R Reichman; K F Wagner; R Chung; J Lane; C S Crumpacker; G X McLeod
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

9.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugs.

Authors:  J E Fitzgibbon; A E Farnham; S J Sperber; H Kim; D T Dubin
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.